Mathematical modeling of tumor growth: the MCF-7 breast cancer cell line

被引:25
作者
Wei, Hsiu-Chuan [1 ]
机构
[1] Feng Chia Univ, Dept Appl Math, Taichung 40724, Taiwan
关键词
breast cancer; MCF-7 cell line; long-term dormancy; mathematical modeling; numerical simulation; NATURAL-KILLER-CELLS; T-CELLS; INDEPENDENT GROWTH; LEUKOCYTE COUNT; SHORT-TERM; ALL-CAUSE; IN-VITRO; IMMUNOTHERAPY; MORTALITY; ESTROGEN;
D O I
10.3934/mbe.2019325
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Breast cancer is the second most commonly diagnosed cancer in women worldwide. MCF-7 cell line is an extensively studied human breast cancer cell line. This cell line expresses estrogen receptors, and the growth of MCF-7 cells is hormone dependent. In this study, a mathematical model, which governs MCF-7 cell growth with interaction among tumor cells, estradiol, natural killer (NK) cells, cytotoxic T lymphocytes (CTLs) or CD8+ T cells, and white blood cells (WBCs), is proposed. Experimental data are used to determine functional forms and parameter values. Breast tumor growth is then studied using the mathematical model. The results obtained from numerical simulation are compared with those from clinical and experimental studies. The system has three coexisting stable equilibria representing the tumor free state, a microscopic tumor, and a large tumor. Numerical simulation shows that an immune system is able to eliminate or control a tumor with a restricted initial size. A healthy immune system is able to effectively eliminate a small tumor or produces long-term dormancy. An immune system with WBC count at the low parts of the normal ranges or with temporary low NK cell count is able to eliminate a smaller tumor. The cytotoxicity of CTLs plays an important role in immune surveillance. The association between the circulating estradiol level and cancer risk is not significant.
引用
收藏
页码:6512 / 6535
页数:24
相关论文
共 107 条
[1]   Molecular mechanisms underlying tumor dormancy [J].
Almog, Nava .
CANCER LETTERS, 2010, 294 (02) :139-146
[2]   Advances in immunotherapy for treatment of lung cancer [J].
Alvarez, Jean G. Bustannante ;
Gonzalez-Cao, Maria ;
Karachaliou, Niki ;
Santarpia, Mariacarmela ;
Viteri, Santiago ;
Teixido, Cristina ;
Rosell, Rafael .
CANCER BIOLOGY & MEDICINE, 2015, 12 (03) :209-222
[3]   Cytotoxic T cells [J].
Andersen, Mads Hald ;
Schrama, David ;
Straten, Per thor ;
Becker, Juergen C. .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2006, 126 (01) :32-41
[4]   Qualitative behavior of systems of tumor-CD4+-cytokine interactions with treatments [J].
Anderson, Luke ;
Jang, Sophia ;
Yu, Jui-Ling .
MATHEMATICAL METHODS IN THE APPLIED SCIENCES, 2015, 38 (17) :4330-4344
[5]  
[Anonymous], 2012, J MATH SYST SCI
[6]   Circulating Estrogen Metabolites and Risk for Breast Cancer in Premenopausal Women [J].
Arslan, Alan A. ;
Shore, Roy E. ;
Afanasyeva, Yelena ;
Koenig, Karen L. ;
Toniolo, Paolo ;
Zeleniuch-Jacquotte, Anne .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2009, 18 (08) :2273-2279
[7]   Delay-induced model for tumor-immune interaction and control of malignant tumor growth [J].
Banerjee, Sandip ;
Sarkar, Ram Rup .
BIOSYSTEMS, 2008, 91 (01) :268-288
[8]   White cell count, mortality, and metabolic syndrome in the Baltimore longitudinal study of aging [J].
Bell, David S. H. ;
O'Keefe, James H. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 50 (18) :1810-1810
[9]  
Bernard S., 2017, J CANC CLIN TRIALS, V2, P131
[10]   Natural killer cells as helper cells in dendritic cell cancer vaccines [J].
Betina Pampena, Maria ;
Mariel Levy, Estrella .
FRONTIERS IN IMMUNOLOGY, 2015, 6